DTIAM: A unified framework for predicting drug-target interactions, binding affinities and activation/inhibition mechanisms

Zhangli Lu,Chuqi Lei,Kaili Wang,Libo Qin,Jing Tang,Min Li

2023-12-23

Abstract:Accurate and robust prediction of drug-target interactions (DTIs) plays a vital role in drug discovery. Despite extensive efforts have been invested in predicting novel DTIs, existing approaches still suffer from insufficient labeled data and cold start problems. More importantly, there is currently a lack of studies focusing on elucidating the mechanism of action (MoA) between drugs and targets. Distinguishing the activation and inhibition mechanisms is critical and challenging in drug development. Here, we introduce a unified framework called DTIAM, which aims to predict interactions, binding affinities, and activation/inhibition mechanisms between drugs and targets. DTIAM learns drug and target representations from large amounts of label-free data through self-supervised pre-training, which accurately extracts the substructure and contextual information of drugs and targets, and thus benefits the downstream prediction based on these representations. DTIAM achieves substantial performance improvement over other state-of-the-art methods in all tasks, particularly in the cold start scenario. Moreover, independent validation demonstrates the strong generalization ability of DTIAM. All these results suggested that DTIAM can provide a practically useful tool for predicting novel DTIs and further distinguishing the MoA of candidate drugs. DTIAM, for the first time, provides a unified framework for accurate and robust prediction of drug-target interactions, binding affinities, and activation/inhibition mechanisms.

Biomolecules,Machine Learning

What problem does this paper attempt to address?

### The Problem Addressed by the Paper

This paper aims to address several key issues in drug-target interaction (DTI) prediction:

1. **Lack of High-Quality Annotated Data**: Most existing methods heavily rely on large-scale high-quality annotated data, which is insufficient, costly, and time-consuming to obtain.
2. **Cold Start Problem**: When identifying new drugs or new targets, existing methods often exhibit limited generalization ability, similar to the cold start problem in recommendation systems.
3. **Insufficient Mechanism Elucidation**: Existing methods fail to adequately elucidate the mechanisms of action (MoA) between drugs and targets, particularly the distinction between activation and inhibition mechanisms.

### The Method Proposed by the Paper

To address the above issues, the authors developed the DTIAM framework, a unified framework for predicting drug-target interactions (DTI), binding affinity (DTA), and activation/inhibition mechanisms (MoA). DTIAM learns representations of drugs and targets from large amounts of unlabeled data through self-supervised pre-training, thereby extracting substructure and contextual information to improve the performance of downstream tasks.

### Main Contributions

- **Self-Supervised Pre-Training**: DTIAM utilizes multi-task self-supervised pre-training to extract features of drugs and targets from large-scale unlabeled data.
- **Performance Improvement in Cold Start Scenarios**: In cold start scenarios, DTIAM significantly outperforms other baseline methods.
- **Mechanism Prediction**: For the first time, a unified framework is provided that can distinguish between activation and inhibition mechanisms, aiding mechanism research in the drug discovery process.
- **Broad Applicability**: DTIAM demonstrates excellent predictive performance and good generalization ability across multiple experimental settings.